ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 144 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $15,000 | -11.8% | 445 | -28.8% | 0.01% | 0.0% |
| Q3 2016 | $17,000 | +13.3% | 625 | -6.7% | 0.01% | 0.0% |
| Q2 2016 | $15,000 | -25.0% | 670 | 0.0% | 0.01% | -16.7% |
| Q1 2016 | $20,000 | -9.1% | 670 | 0.0% | 0.01% | -14.3% |
| Q4 2015 | $22,000 | -8.3% | 670 | 0.0% | 0.01% | +40.0% |
| Q3 2015 | $24,000 | – | 670 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,546,097 | $66,590,000 | 9.91% |
| RA Capital Management | 1,539,586 | $66,310,000 | 6.70% |
| SENZAR ASSET MANAGEMENT, LLC | 255,128 | $10,988,000 | 4.20% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 158,315 | $6,819,000 | 1.56% |
| Sarissa Capital Management LP | 105,000 | $4,522,000 | 1.54% |
| Ghost Tree Capital, LLC | 50,000 | $2,154,000 | 1.52% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 118,445 | $5,102,000 | 0.90% |
| WALL STREET ASSOCIATES | 219,200 | $9,441,000 | 0.81% |
| Granite Point Capital Management, L.P. | 25,000 | $1,077,000 | 0.74% |
| BAILARD, INC. | 91,500 | $3,941,000 | 0.61% |